Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by XTX Topco Ltd

XTX Topco Ltd trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 63.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 122,428 shares of the pharmacy operator’s stock after selling 211,541 shares during the period. XTX Topco Ltd’s holdings in Walgreens Boots Alliance were worth $1,142,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in WBA. Vanguard Group Inc. grew its position in shares of Walgreens Boots Alliance by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock worth $805,506,000 after buying an additional 2,279,495 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Walgreens Boots Alliance by 8.8% during the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator’s stock valued at $303,902,000 after buying an additional 2,631,332 shares during the last quarter. Geode Capital Management LLC boosted its position in Walgreens Boots Alliance by 5.2% during the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator’s stock worth $194,082,000 after acquiring an additional 1,020,587 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Walgreens Boots Alliance by 19.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock worth $122,737,000 after purchasing an additional 2,185,950 shares during the period. Finally, Norges Bank bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $58,241,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $10.85 on Wednesday. The firm has a market capitalization of $9.38 billion, a PE ratio of -1.06, a PEG ratio of 1.31 and a beta of 0.67. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $18.83. The company’s 50-day moving average is $10.78 and its 200-day moving average is $10.10.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. During the same quarter in the previous year, the firm earned $1.20 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 4.1% compared to the same quarter last year. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently weighed in on WBA shares. Evercore ISI raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Royal Bank of Canada boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price target for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, StockNews.com assumed coverage on Walgreens Boots Alliance in a report on Friday, April 11th. They set a “hold” rating on the stock. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus target price of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.